Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

ChartsAnalysisChatData
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources
←Back to briefings
Rakon (RAK) / HY23

Inventory build of $28.5m wiped operating cash flow despite PBT up 14.9%

PBT grew 14.9% on 2.0% revenue growth, but a $28.5m inventory build cut operating cash flow from $4.5m to $0.0m and turned free cash flow negative.

Technology / Electronics

RAK revenue trajectory

Revenue context before the current result.

↗
Loading chart...
HY26 was $54.2m, versus $41.7m in HY25.

RAK EBITDA margin

EBITDA margin across covered periods.

↗
Loading chart...
HY26 was 6.6%, versus -37.9% in HY25.

RAK operating cash flow

Operating cash flow across covered periods.

↗
Loading chart...
HY26 was $6.4m, versus $8.3m in HY25.

RAK working-capital movement

Operating working-capital absorption or release by reporting period.

↗
Loading chart...
  • HY24 RAK: Outside range high operating working-capital movement. $33.8m; 3-period range $-18.7m to $28.4m. Operating working-capital movement: NZ$33.8m, above normal range; 2/3 prior periods had builds averaging NZ$26.2m, and 1 had releases averaging NZ$-18.7m.
  • HY25 RAK: Outside range low operating working-capital movement. $-18.7m; 3-period range $24m to $33.8m. Operating working-capital movement: NZ$-18.7m, below normal range; 3/3 prior periods had builds averaging NZ$28.7m, and none had a working-capital release.
Operating working-capital movement: NZ$-18.7m, below normal range; 3/3 prior periods had builds averaging NZ$28.7m, and none had a working-capital release.
Release date
24 November 2022
Published
22 April 2026
Ask about this result
Sections⌄
  1. Charts
  2. Analysis
  3. Chat
  4. Data
  5. Sources

Key metrics

Numbers worth scanning first

HY23 vs HY22

Revenue

$87.2m

+2.0% ↑ vs $85.4m

EBITDA

—

— vs $26.4m

Net profit after tax

$16m

-15.3% ↓ vs $18.9m

Net cash inflow from operating activities

$0.02m

Suppressed: metric quality flags mark this value as unsuitable for normal comparison.

Operating profit

$22.9m

+19.9% ↑ vs $19.1m

Profit before tax

$22.4m

+14.9% ↑ vs $19.5m

Cash and cash equivalents

$25.7m

+29.2% ↑ vs $19.9m

Total assets

$218.4m

+23.1% ↑ vs $177.4m

What changed

The standout movement is the near-total collapse of operating cash flow, which fell from $4.5m to $0.0m as inventories swelled by $28.5m (+65.4%) to $72.0m

Revenue rose 2.0% to $87.2m and PBT advanced 14.9% to $22.4m, but reported NPAT fell 15.3% to $16.0m because the effective tax rate normalised from 2.7% to 28.5%. Capex more than doubled to $9.4m, lifting capex intensity to 10.8% of revenue from 4.7%, which turned free cash flow pre-lease to -$9.4m from +$0.5m. Despite the cash drain in the half, gross borrowings fell to $7.3m from $16.3m and cash rose to $25.7m, leaving Rakon in a stronger net cash position than a year ago.

What matters

Cash conversion has broken away from earnings

  • OCF/EBITDA fell from 17.1% to 0.1% as inventory absorbed nearly the entire operating result. Free cash flow to NPAT swung to -58.7%, so a 14.9% PBT advance has produced no cash. This matters because the underlying business looks healthier on the income statement than the cash flow can yet validate, and the working-capital cycle, not trading, is now the binding constraint.

  • Tax normalisation, not operating weakness, explains the NPAT fall. PBT grew 14.9% while NPAT fell 15.3% — a 30.2pp gap driven entirely by the effective tax rate moving from 2.7% to 28.5%. The cleaner operating read is PBT growth. Treating the headline NPAT decline as evidence of business deterioration would misread the period.

  • Capex is stepping up alongside inventory. Capex more than doubled to $9.4m, against an FY22 first-half base of $4.0m. Combined with the inventory build, Rakon is committing balance sheet ahead of revenue. That is a bet on the demand outlook holding; if second-half volumes do not lift, the cash position absorbs further pressure.

Expectations

There are no stated targets in the release

The supplied shape context shows HY22 represented 49.7% of FY22 revenue, so the first half is roughly balanced on revenue, while NPAT was first-half weighted at 57.2% of FY22. Annualised current revenue of $174.3m is broadly in line with FY22's $172.0m, so the run-rate is flat even as PBT growth is stronger.

The inventory and capex stance implies management expects a second-half volume lift. The release does not quantify forward orders, so the gap between that internal assumption and external visibility is the central uncertainty for the result.

Quality of result

The durable elements are the 14.9% PBT growth on only 2.0% revenue growth, indicating real operating leverage, and the segment margin profile — Space & Defence at 69.1% and Positioning at 56.7% gross margin, with Telecommunications (54.5% of revenue) at 42.1%

The balance sheet has also strengthened, with gross borrowings more than halving and net cash deepening.

The less durable elements are more pointed. The NPAT comparison is corrupted by the tax-rate reset, so any headline earnings narrative overstates prior-year underlying performance. Operating cash flow of $0.017m provides no support for the PBT growth, and the inventory and capex build together produced a $9.4m free cash outflow. ROE fell from 14.8% to 12.3%, reflecting both the higher tax rate and a larger equity base. Underlying EBITDA growth of 6% is partly attributed to foreign exchange gains in the commentary, so the operating-only contribution is smaller than the headline implies.

Unresolved

Open questions

What demand assumptions justify the $28.5m inventory build, and over what period does management expect this to unwind into cash?
Why did capex more than double to $9.4m, and how much further is committed for the India manufacturing facility and other capacity?
Is the 28.5% effective tax rate now the run-rate, or does it contain catch-up or jurisdictional items?
How much of the 6% underlying EBITDA increase reflects FX gains versus underlying margin expansion?
Whether the order book supports the inventory and capex stance into the second half.

This briefing cannot assess Rakon's forward order visibility or the likely timing of inventory conversion to cash, as no forward-work disclosure is supplied.

Chat

Ask about RAK HY23

Ask follow-up questions about Rakon's HY23 result.

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Ask about RAK HY23

Informational only. No buy, sell, hold, price-target, or personal financial advice.

Sign in to chat

Sign in to ask questions about Rakon's HY23 result.

What demand assumptions justify the $28.5m inventory build, and over what period does management expect this to unwind into cash?Why does "Cash conversion has broken away from earnings" matter?How strong was the cash and earnings quality in HY23?What should I watch next for RAK after HY23?

Checking account...

Data appendix

Show segment detail

Open to load segment breakdown.

Show analytical metrics

Open to load analytical metrics.

Show key metrics table

Open to load key metrics.

Sources

Current period

Rakon 1H23 Financial Results & Business Update - Presentation

HY23 / results presentation↗

Rakon 1H23 Interim Report

HY23 / financial report↗

Rakon 1H23 Results Announcement

HY23 / results announcement↗

Rakon 1H23 Results Announcement Commentary

HY23 / results release↗

Prior comparable period

Rakon 1H22 Interim Report

HY22 / financial report↗

Rakon 1H22 Results Announcement

HY22 / results announcement↗

Rakon 1H22 Results Announcement

HY22 / results release↗

Full-year context

Rakon Annual Report 2022

FY22 / financial report↗

Rakon FY22 Results Announcement

FY22 / results announcement↗

Rakon FY22 Results Announcement

FY22 / results release↗

Release context

Rakon 1H23 Results Business Update Webcast & Teleconference

HY23 / commentary↗

RAKON FY23 EARNINGS GUIDANCE

HY23 / commentary↗

Related insights

Cross-company views selected from the metrics in this briefing.

Cash conversion quality

This result converted 0.1% of EBITDA to operating cash flow, -17.0pp versus the prior comparable period.

→

Earnings quality and statutory distortions

PBT and NPAT growth diverged by 30.2pp, with a distortion flag in the result.

→

Leverage and balance-sheet risk

Net debt / EBITDA is -0.66x, -0.52x versus the prior comparable period.

→

ROE and capital efficiency

ROE was 12.3%, -2.5pp versus the prior comparable period.

→
This briefing is based on available company filings and standard Annolyse calculations. It is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Get notified when RAK publishes next

Get the next Rakon briefing and related NZX reporting-season updates by email.